Privia Health Group (PRVA) Stock Forecast: StockMap's 2-Week Call
PRVA stock forecast: StockMap's model leans Outperform on Privia Health Group for the two weeks after the Nov 19 close, toward PRVA doing better than the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 2 of 5 two-week windows on PRVA since Aug 21; by chance, a call on the same dates was right 65% of the time.
Privia Health Group last closed at $24.69, +0.37% on the session.
Against the IVW growth benchmark the position is +2.70% over the forecast window.
Privia Health Group's market cap is $3.15B as of November 19, 2026.
Leans up ↗: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 24 (too close to call).
Where PRVA sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 7 bullish and 8 bearish.
Agreement across those insights is 47%.
24 daily calls for PRVA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Privia Health Group in the 5th percentile on valuation and the 46th percentile on return on equity, where 100 is best.
Privia Health Group is classified under Health Care / Health Care Providers & Services.
StockMap tracks Privia Health Group as the 35th largest of the 87 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 52 Neutral, 18 Moderate Underperform, 12 Moderate Outperform and 5 Strong Underperform.
On that composite Privia Health Group ranks 12th of 87 in the group, against a group median of -0.06.